Home > Balance Sheet > NATCO PHARMA

NATCO PHARMA
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
NATCO PHARMA is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Deferred Tax Assets / Liabilities ₹-19 Cr₹12 Cr₹30 Cr₹41 Cr₹26 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of NATCO PHARMA ?

The latest Deferred Tax Assets / Liabilities ratio of NATCO PHARMA is ₹-19 Cr based on Mar2024 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2024₹-19 Cr
Mar2023₹12 Cr
Mar2022₹30 Cr
Mar2021₹41 Cr
Mar2020₹26 Cr

How is Deferred Tax Assets / Liabilities of NATCO PHARMA Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2024 ₹-19 Cr
Negative
Mar2023 ₹12 Cr
-58.80
Mar2022 ₹30 Cr
-27.12
Mar2021 ₹41 Cr
59.46
Mar2020 ₹26 Cr -

Compare Deferred Tax Assets / Liabilities of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹22,197.7 Cr 2.2% -14.3% 47.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹428,557.0 Cr 2.3% -0.8% 32.7% Stock Analytics
DIVIS LABORATORIES ₹156,994.0 Cr 3.2% 1.1% 51.5% Stock Analytics
CIPLA ₹116,494.0 Cr 0.3% -2% 10% Stock Analytics
DR REDDYS LABORATORIES ₹109,297.0 Cr -1.8% 2.7% 12.7% Stock Analytics
ZYDUS LIFESCIENCES ₹100,035.0 Cr 2% 1.5% 38% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

2.2%

-14.3%

47.1%

SENSEX

-1%

-5%

5.6%


You may also like the below Video Courses